ClinicalTrials.Veeva

Menu

Non-invasive Brain Stimulation in Adults Who Stutter

University of Michigan logo

University of Michigan

Status

Terminated

Conditions

Stuttering, Developmental

Treatments

Device: Sham tDCS
Behavioral: Fluency training
Device: Anodal tDCS

Study type

Interventional

Funder types

Other

Identifiers

NCT03437512
HUM00134495

Details and patient eligibility

About

Research studies in stuttering have shown that activity patterns in certain brain areas differ in people who stutter compared to people who do not stutter when speaking. The purpose of this study is to investigate how mild, non-invasive brain stimulation applied consecutively for five days affects speech relevant brain areas, which may in turn affect speech fluency and speaking-related brain activity in people who stutter.

Enrollment

29 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • history of persistent developmental stuttering
  • stuttering severity ranging from mild to very severe, specifically Stuttering Severity Instrument (SSI) total score of 20 (mild) or higher and stuttering rates of 3% or higher
  • scores within 1 standard deviation of the norm on the standardized tests for the study

Exclusion criteria

  • received any treatment for stuttering within the past year
  • other neurological conditions such as Tourette's syndrome or post-traumatic stress disorder
  • taking any medications/drugs that affect brain function
  • history of past or current mental illness for example, schizophrenia that may affect brain development and function
  • history of serious medical or neurological illness such as epilepsy and Parkinson's disease
  • history of closed head injury (e.g., concussion)
  • history of reading disorders
  • hearing loss
  • taking any medication, prescription or non-prescription with any psychotropic effects at the time of the study
  • metal or electronic implants such as cochlear implants, and pacemakers

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

29 participants in 2 patient groups

Active tDCS and fluency training
Experimental group
Description:
Participants will receive anodal tDCS at 2milliampere (mA) intensity for 20 minutes during speech fluency training (5 consecutive days).
Treatment:
Device: Anodal tDCS
Behavioral: Fluency training
Sham tDCS and fluency training
Sham Comparator group
Description:
Participants will receive sham tDCS. Sham stimulation will involve 30 seconds of stimulation at the beginning of the 20 minutes of speech fluency training (5 consecutive days).
Treatment:
Device: Sham tDCS
Behavioral: Fluency training

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems